Source:http://linkedlifedata.com/resource/pubmed/id/18322152
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
3
|
pubmed:dateCreated |
2008-5-16
|
pubmed:abstractText |
We hypothesized that the 5-hydroxytryptamine (5-HT; serotonin) system is present and functional in veins. In vena cava (VC), the presence of the 5-HT synthesis rate-limiting enzyme tryptophan hydroxylase-1 mRNA and accumulation of the 5-HT synthesis intermediate 5-hydroxytryptophan after incubation with tryptophan supported the ability of veins to synthesize 5-HT. The presence of 5-HT and its metabolite 5-hydroxyindole acetic acid was measured by high-performance liquid chromatography in VC and jugular vein (JV), and it was compared with similarly sized arteries aorta (RA) and carotid (CA), respectively. In rats treated with the monoamine oxidase-A (MAO-A) inhibitor pargyline to prevent 5-HT metabolism, basal 5-HT levels were higher in veins than in arteries. 5-HT uptake was observed after exposure to exogenous 5-HT in all vessels. The presence of MAO-A and the 5-HT transporter (SERT) in VC was observed by immunohistochemistry and Western analysis. However, 5-HT uptake was not inhibited by the SERT inhibitors fluoxetine and/or fluvoxamine in VC and JV, as opposed to the inhibition in RA and CA. Moreover, studies performed in VC from mutant rats lacking SERT showed no differences in 5-HT uptake compared with VC from wild type. These data suggest the SERT is not functional under physiological conditions in veins. The differences in 5-HT handling between veins and arteries may represent alternative avenues for targeting the 5-HT system in the peripheral circulation for controlling vascular tone.
|
pubmed:grant | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Hydroxyindoleacetic Acid,
http://linkedlifedata.com/resource/pubmed/chemical/Monoamine Oxidase,
http://linkedlifedata.com/resource/pubmed/chemical/RNA, Messenger,
http://linkedlifedata.com/resource/pubmed/chemical/Serotonin,
http://linkedlifedata.com/resource/pubmed/chemical/Serotonin Plasma Membrane...,
http://linkedlifedata.com/resource/pubmed/chemical/Tryptophan Hydroxylase,
http://linkedlifedata.com/resource/pubmed/chemical/tph1 protein, rat
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jun
|
pubmed:issn |
1521-0103
|
pubmed:author | |
pubmed:issnType |
Electronic
|
pubmed:volume |
325
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
714-22
|
pubmed:meshHeading |
pubmed-meshheading:18322152-Animals,
pubmed-meshheading:18322152-Animals, Genetically Modified,
pubmed-meshheading:18322152-Aorta,
pubmed-meshheading:18322152-Carotid Arteries,
pubmed-meshheading:18322152-Hydroxyindoleacetic Acid,
pubmed-meshheading:18322152-Intestinal Mucosa,
pubmed-meshheading:18322152-Jugular Veins,
pubmed-meshheading:18322152-Male,
pubmed-meshheading:18322152-Monoamine Oxidase,
pubmed-meshheading:18322152-RNA, Messenger,
pubmed-meshheading:18322152-Rats,
pubmed-meshheading:18322152-Rats, Sprague-Dawley,
pubmed-meshheading:18322152-Rats, Wistar,
pubmed-meshheading:18322152-Serotonin,
pubmed-meshheading:18322152-Serotonin Plasma Membrane Transport Proteins,
pubmed-meshheading:18322152-Tryptophan Hydroxylase,
pubmed-meshheading:18322152-Venae Cavae
|
pubmed:year |
2008
|
pubmed:articleTitle |
A serotonergic system in veins: serotonin transporter-independent uptake.
|
pubmed:affiliation |
Department of Pharmacology and Toxicology, Michigan State University, B445 Life Sciences Bldg., East Lansing, MI 48824, USA. linderau@msu.edu
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't,
Research Support, N.I.H., Extramural
|